Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells

This publication has 41 references indexed in Scilit:

• Therapeutic Effects of Coenzyme Q10 in Neurodegenerative Diseases
  Published by Elsevier ,2004
• Effects of Coenzyme Q₁₀ in Huntington's disease and early Parkinson's disease
  BioFactors, 2003
• Coenzyme Q 10 as a Possible Treatment for Neurodegenerative Diseases
  Free Radical Research, 2002
• Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease
  Neurosignals, 2001
• Uncoupling proteins 2 and 3 are highly active H ⁺ transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone)
  Proceedings of the National Academy of Sciences, 2001
• Enhanced sensitivity of ubiquinone-deficient mutants of Saccharomyces cerevisiae to products of autoxidized polyunsaturated fatty acids.
  Proceedings of the National Academy of Sciences, 1996
• The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions.
  Proceedings of the National Academy of Sciences, 1995
• An analysis of the role of coenzyme Q in free radical generation and as an antioxidant
  Biochemistry and Cell Biology, 1992
• Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)
  Acta Neurologica Scandinavica, 1991
• Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q ₁₀
  Neurology, 1988